| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |